We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Barr Laboratories is raising the stakes in its battle with Actavis to acquire Croatian drugmaker Pliva, announcing it is countering Actavis’ most recent bid.
As the Japanese regulatory landscape shifts toward shorter approval times, one firm recently emerged from a nine-year process to tell its tale of what it takes to get a device into the Japanese market.
A study has found that Celebrex, a pain drug made by Pfizer that belongs to the same class of drugs as the discredited drug Vioxx, may slow or prevent the onset of colon cancer.
Skilled use of outsourcing can save drugmakers money, time and headaches, but it doesn't absolve them of ultimate responsibility for their product and data, a former FDA official said.
Authors of a new report say it exonerates Merck from allegations that the company knowingly kept its painkiller Vioxx on the market despite underlying cardiovascular risks, but investigators also condemn Merck’s “poor judgment and errors,” including public statements that downplayed the health hazards.
Authors of a new report say it exonerates Merck from allegations that the company knowingly kept its painkiller Vioxx on the market despite underlying cardiovascular risks, but investigators also condemn Merck’s “poor judgment and errors,” including public statements that downplayed the health hazards,
The Greek antitrust regulatory agency has dismissed a complaint filed against GlaxoSmithKline (GSK) by a group of pharmacists, wholesalers and distributors claiming the company improperly restrained trade in that country.